Background Evidence supports early laparoscopic cholecystectomy for acute cholecystitis. Differences in treatment patterns between the USA and UK, associated outcomes and resource utilization are not well understood. Methods In this retrospective, observational study using national administrative data, emergency patients admitted with acute cholecystitis were identified in England (Hospital Episode Statistics 1998 and USA (National Inpatient Sample 1998 -2011 . Proportions of patients who underwent emergency cholecystectomy, utilization of laparoscopy and associated outcomes including length of stay (LOS) and complications were compared. The effect of delayed treatment on subsequent readmissions was evaluated for England. Results Patients with a diagnosis of acute cholecystitis totaled 1,191,331 in the USA vs. 288 907 in England. Emergency cholecystectomy was performed in 628,395 (52.7% USA) and 45,299 (15.7% England) over the time period. Laparoscopy was more common in the USA (82.8 vs. 37.9%; p < 0.001). Pre-treatment (1 vs. 2 days; p < 0.001) and total ( 4 vs. 7 days; p < 0.001) LOS was lower in the USA. Overall incidence of bile duct injury was higher in England than the USA (0.83 vs. 0.43%; p < 0.001), but was no different following laparoscopic surgery (0.1%). In England, 40.5% of patients without an immediate cholecystectomy were subsequently readmitted with cholecystitis. An additional 14.5% were admitted for other biliary complications, amounting to 2.7 readmissions per patient in the year following primary admission. Conclusion This study highlights management practices for acute cholecystitis in the USA and England. Despite best evidence, index admission laparoscopic cholecystectomy is performed less in England, which significantly impacts subsequent healthcare utilization.
immediate and long terms in the UK has not to date been evaluated.
In the United States, the standard of care is laparoscopic cholecystectomy within 48-72 h [7] . In the United Kingdom, National Institute for Health and Care Excellence (NICE) guidelines, implemented in 2011 and updated in 2017, state laparoscopic cholecystectomy should be performed within one week of presentation [8] but despite a drive towards providing early surgery, many patients in the UK are still initially managed conservatively with planned delayed cholecystectomy 6-8 weeks following discharge [9] .
We used two large administrative population databases to evaluate differences in international practice patterns in the surgical management of acute cholecystitis between the USA and England. We sought to answer three main questions: Firstly, what proportion of patients in each country with a diagnosis of acute cholecystitis receive an early definitive cholecystectomy, and by the laparoscopic approach, during their emergency admission? Secondly, what are the associated in-hospital outcomes in both countries including pretreatment and total length of hospital stay as well as bile duct injury and selected complications? Finally, what is the effect of delaying cholecystectomy on subsequent admissions and post-discharge events in England?
Methods
The Columbia University Medical Center Institutional Review Board deemed this research not human subjects research under 45 CFR 46. This study is reported according to STROBE guidelines.
Patient involvement
No patients were involved.
Data
The US and English datasets used for comparison have been reported and described in previous international comparisons, and are outlined below [10] .
US data
The Nationwide Inpatient Sample (NIS) data 1998-2011 were obtained from The Healthcare Costs and Utilisation Project (HCUP). NIS is the largest US all-payer inpatient administrative database containing demographic and clinical information on a 20% sample of all patient discharges from all hospitals located across 45 states, encompassing 96% of the US population. Data represent all regions of the US, both rural and urban environments, as well as all hospital types (teaching, non-teaching) and information on patients covered by Medicare, Medicaid, private insurers as well as those uninsured. Data here are weighted according to HCUP methods to represent the US population as a whole. All data elements are derived from hospital discharge abstracts and include data pertaining to that admission, with no available patient information beyond an in-hospital episode [11] .
English data
Hospital Episode Statistic (HES) data 1998-2012 were obtained from The Health and Social Care Centre. HES is an administrative data warehouse containing patient, diagnostic and procedural details of all admissions, outpatient appointments and Emergency Department attendances at NHS hospitals in England. It is a records-based system that covers all NHS trusts. Each patient is given a unique HES identifier that allows patient tracking and follow-up admissions to be captured [12] .
Data management
Differences between the two countries' administrative datasets were taken into careful consideration. Firstly, the US data contain detail on in-hospital events, whereas the English sample is a collection of separate records-one for each period of care and can therefore be linked over time using a unique patient identifier. Only in-hospital data from the primary admission were used for country comparisons to account for this. Secondly, international data are coded differently: ICD-10 diagnostic and OPCS-4 procedural codes are used in England compared to ICD-9 CM in the US (see Online Appendix). All relevant codes were hand-searched and checked for accurate matched descriptions. Finally, postoperative outcomes for comparison were limited to those with directly correlated codes, for example, unlike the US dataset there is no direct ICD-10 code in the English dataset that identifies surgical site infection.
The datasets were created and cleaned separately, then uploaded to a Health Insurance Portability and Accountability Act (HIPAA)-approved secure shared server for comparative analysis.
Inclusion criteria comprised patients over 18 years who were admitted as emergencies and with a recorded primary diagnosis of acute cholecystitis. Patients with chronic cholecystitis or any other biliary diagnoses were excluded. Patients were grouped into those that received an emergent/urgent cholecystectomy (laparoscopic or open) on the same admission vs. those that received other treatments (including percutaneous cholecystostomy and non-operative or endoscopic management). Patient-level variables included age, gender, year of admission and Charlson Index (CI) as a measure of comorbidity. A pre-validated comorbidity technique was used to define CI separately for the US and England using secondary diagnosis codes [13] .
Primary outcome was emergency cholecystectomy on the index admission for acute cholecystitis. Secondary outcomes were rates of laparoscopic cholecystectomy vs. open, pre-operative and total length of hospital stay, major bile duct injury and selected outcomes. A laparoscopic procedure was defined in both countries as any procedure with an associated laparoscopic code. According to an intention-to-treat analysis, this included laparoscopic operations subsequently converted to open. We identified only in-hospital post-operative complications due to limitations of the US dataset, which meant an inability to track adverse effects beyond the first in-hospital episode. We defined bile duct injuries as those that required surgical reconstruction (classified as major bile duct injuries) as opposed to any biliary injury, consistent with previous literature [14] . Primary and secondary diagnostic codes for major bile duct injury were US ICD-9CM: 51 [15] .
English data only
A subset analysis of patients who did not undergo emergency cholecystectomy at index admission was performed and the impact of delay on subsequent readmissions evaluated. Patients were followed up for 1 year or until cholecystectomy.
Statistical analysis
Descriptive statistics for patient characteristics, treatment and operative approach were compared between the two countries. Univariate analyses of clinical outcomes from emergency cholecystectomy for acute cholecystitis in the US and England were performed. Continuous variables are presented as means ± standard deviation or medians [Interquartile Range-IQR] and compared using students paired t test, categorical variables are shown as percentages and compared with Chi-squared (χ 2 ) test (Table 1) . Multivariable logistic regression analyses were performed to identify the independent effect of country on the likelihood of receiving a laparoscopic approach to emergency cholecystectomy while accounting for age, Charlson Comorbidity Index and calendar year. Patients with any missing data on age, comorbidity, year of operation or surgical approach were less than 1% and excluded. Effect sizes were reported as Odds Ratios (OR) with their accompanying measure of uncertainty (95% Confidence Interval-CI). A p value of < 0.05 was deemed statistically significant. Analysis was performed using SPSS version 19.0 software (SPSS, Chicago, Illinois).
Results

Early cholecystectomy
A total of 1,191,331 patients in the USA and 288,907 in England were admitted as an emergency with a primary diagnosis of acute cholecystitis. Over the 15-year study period, 628,395 (52.7%) USA and 45,299 (15.7%) England patients, respectively, received an emergency cholecystectomy on admission ( Fig. 1) , of which 520,156 (82.8%) in the USA and 17,174 (37.9%) in England were laparoscopic. Over time, there was no meaningful increase in the incidence In 2011, the most recent years' available data for both countries, 55.6% of US patients received cholecystectomy on their index admission vs. only 16.5% of English patients; the proportion of those that were laparoscopic was similar, but still lower, in England (84.0 vs. 89.1%, p < 0.001).
On regression analyses, for patients who had surgery performed at their index admission, England was independently associated with a lower utilization of laparoscopic approach to cholecystectomy (OR 0.088; 95% CI 0.086-0.090) ( Table 2 ). This accounted for Charlson comorbidity, which was notably higher in the US.
Outcomes
In the USA group, average pre-treatment (2.0 vs. 3.0 days; p < 0.001) and total LOS (4.0 vs. 7.0 days; p < 0.001) were both lower (Table 3) .
The incidence of bile duct injury requiring surgical reconstruction for all emergency cholecystectomies was higher in England compared to the USA (0.83 vs. 0.43%; p < 0.001). There was a significant reduction in the rate of bile duct 
Discussion
Utilizing two large, nationally representative, administrative databases, we showed that the rate of definitive cholecystectomy for patients who present as emergencies with acute cholecystitis is far higher in the Unites States than in England (53 vs. 16%). The rate of early emergency operation also did not meaningfully increase from 1998 to 2012 in England and when performed, the laparoscopic approach was used less frequently compared to the US. US patients showed some improved perioperative outcomes and a shorter length of hospital stay. The low use of cholecystectomy during index admission in England was associated with a significant subsequent burden to the healthcare system. Over half of patients who did not receive immediate cholecystectomy went on to develop gallstonerelated complications resulting in readmission and even after a year, more than 50% had still not received definitive cholecystectomy. Considering that emergency laparoscopic cholecystectomy during admission for cholecystitis is safe, and with both countries showing equally low rates of bile duct injury, these findings have key implications for the management of acute cholecystitis in England. Comparing treatment patterns between different health systems is not without limitations, however, international benchmarking can highlight wide disparities in practice, which may not be as stark in a national study, and may therefore be used to drive best practice [10] .
A number of randomized controlled trials and metaanalyses have shown that early cholecystectomy is associated with reduced complications, shorter length of stay and lower costs [16] [17] [18] [19] [20] [21] . A Cochrane review and meta-analysis included seven randomized trials and found that while early surgery did not affect the proportion of patients who developed complications or required conversion to an open procedure, it did decrease hospital stay and reduce the risk of emergency surgery at a later date for recurrent or unresolved symptoms [22] . Studies evaluating the relationship between days to surgery from admission have shown optimal outcomes at day 0-1, with any subsequent daily delay resulting in increasing operative time, conversion rate, hospital stay, costs and complications [16, 23, 24] . Recently, time to cholecystectomy has also been suggested as a potential quality indicator, with an index cholecystectomy rate of 75% for all admissions of acute biliary disease thought realistic and achievable [25] . In a cost-utility analysis from the UK NHS perspective, early cholecystectomy has been shown to be less costly and more clinically effective [26] . Using national data and after controlling for patient-and hospital-related factors, costs in the United States have also been shown to increase with every day of delay to operation [27] .
Despite good evidence, national guidance supporting early intervention [28] [29] [30] , and previous published research highlighting the low rate of emergency intervention in the UK [31, 32] , this practice has not become routine. The reasons for this cannot be elucidated from these data, but it raises the question of how best practices are integrated into the NHS once there is clear evidence for their benefit. We know that the rates of early intervention vary widely across the NHS, with higher volume centers performing more (and more laparoscopically), as well as surgeons of greater seniority and level of specialization [32] [33] [34] [35] . The relationship between hospital or surgeon volume and perioperative outcomes is less clear-cut, but some suggest that higher surgeon volumes are associated with better laparoscopic outcomes [28, [36] [37] [38] .
The lack of uptake across England is likely multifactorial, but may include wider system factors such as the degree of centralization for emergency surgery, local factors including the availability of resources (including surgical staff, theatre space and radiological investigations), and of the required laparoscopic and upper gastrointestinal surgical expertise, as well as individual surgeon preference [39] . In order to empower clinicians to bring about change in their local hospitals, The Royal College of Surgeons launched the Cholecystectomy Quality Improvement Collaborative (CholeQuIC) in 2016 [40] . It has been suggested that changes in practice in the UK may be achieved through addressing tensions between managing acute surgical cases and elective operating lists. The recently published "Getting It Right First Time (GIRFT)" report for General Surgery, supported by NHS Improvement and The Royal College of Surgeons, recommends hospitals need better capacity planning with the allocation of operating theatres matched to the emergency surgery workload. This all needs to be managed by good theatre governance as well as dedicated anaesthesia and surgical leadership [40, 41] . Institutional goals of high index cholecystectomy rates may also encourage increased uptake and innovation in service delivery [25] . Introducing a dedicated early cholecystectomy service, or specialist-led approach, in the NHS has been shown to be both feasible and cost efficient [42, 43] . The lack of uptake and implementation of evidence in medicine has been extensively studied and most research demonstrates complex and multifactorial contributing factors, with multiple strategies required to increase adherence. Previously described "Cognitive" theories suggest that poor knowledge is a contributing factor, "behavioural" that external stimuli such as feedback and incentives play a role. "Social influence" theories suggest that it is a lack of embedded social norms and leadership management. Finally, "organizational" theories point to a system failure (as opposed to a doctor issue) and a failure to organize care processes along with a culture that is not focused on collaboration and improvement [44] . While it is likely that similar barriers to uptake exist across different countries, country context-including policies, organizational structures and resources, culture and social norms-will influence uptake differently. Laparoscopy was introduced earlier in the US and saw a rapid uptake. It is possible that increased expertise in the US (both in laparoscopic techniques and as a result of the increased volumes of emergency cases performed) or more routine senior operative involvement in the emergency setting, is responsible for higher rates of emergent surgery. Our English data showed improved outcomes with increased uptake over time, and equivalent rates of major bile duct injury following laparoscopy. Finally, fee-for-service payments predominate in the US, rewarding surgeons and hospitals, for carrying out a greater volume of procedures, and as such this may incentivize early intervention [45] .
While some in-hospital complications were seen to be higher in England, thromboembolic events were lower than the US. We cannot be certain why, but there has been a longstanding quality focus on the prevention of post-operative DVT and PE in England and in 2011, financial incentives were introduced across the NHS [Commissioning for Quality and Innovation (CQUIN)] for a 90% completion rate of venous thromboembolism risk assessment of all adult hospital inpatients [46] . In the US, financial penalties for hospital-acquired conditions, including venous thromboembolism, as a result of the Value-Based Purchasing (VBP) Program were brought in 2012.
We acknowledge a number of limitations; principally those associated with the available datasets and the complexity of cross-national comparisons. Firstly, this is a retrospective observational study using administrative data which are known to contain coding inaccuracies [47, 48] . However, both datasets are used to monitor selected outcomes nationally and quality of administrative data is improving over time [49] . Unmeasured confounders and differences in patient disease severity cannot be accounted for with these data. We excluded patients with coding for chronic cholecystitis (as well as other biliary diagnoses), but in the US data, unlike the UK data, we were unable to determine if patients had had previous admissions with the same diagnosis. In addition, the threshold for a diagnosis of acute cholecystitis and the diagnostic methods used, may differ between the two countries, which would affect the severity of presentation and patient condition. It is possible that in the UK, clinical severity at presentation is greater and operations are being appropriately deferred. However, the widely different rates (53 vs. 16%) suggest that this is unlikely the full picture. Despite efforts to rationalize the two coding systems, there are inevitable discrepancies between country coding definitions and practices. In the US, mandatory reporting of many post-operative events are linked to payments and therefore there is potential for reduced reporting of complications; up-coding of patient risk in the USA has also been reported [50] . In our data, US patients have a higher comorbidity index than the UK, which may reflect differences in secondary diagnosis coding practices. HES coding accuracy was improved following a national drive in 2004. Codes for bile duct reconstruction (major bile duct injury) post-cholecystectomy were used as opposed to less specific codes for a simple bile leak. While the overall rate of BDI in England is double the US rate, there is no difference when the laparoscopic approach is utilized. The reason for the lower overall BDI rate in the US may in part be due to the earlier adoption and higher rates of laparoscopic surgery, or due to transfers of complex patients out of hospital to specialist centres, which is not captured in the US data, but is in England. As such, BDI comparison should be interpreted with caution. HES covers the entire general population treated in acute hospitals in England, whereas NIS represents all discharges from a random 20% of hospitals, which may limit generalizability to the rest of the US. Finally, we include available data up to 2011 in both countries (2012 in England), so changes in practice may have occurred more recently. This study shows that 15.7% of patients in England received cholecystectomy for acute cholecystitis on the primary admission when compared to 52.7% of patients in the USA. In addition, over time there was no significant increase in the incidence of cholecystectomy performed on the initial admission for acute cholecystitis in England, unlike the US. The laparoscopic approach was also used less frequently in England, but when performed had similar rates of BDI to patients in the US. When patients in the UK did not receive early cholecystectomy, a large proportion were readmitted with complications due to the delay. A high proportion of patients also failed to have a definitive procedure at 1 year which may suggest either a high rate of loss to follow-up or lack of access due to long waiting lists, consistent with prior research [51] . The initial conservative management of acute cholecystitis so as to then perform an elective cholecystectomy at a later time places unnecessary burden on stretched elective operating waiting list capacity and results in associated intermediate readmissions, adding significant costs for both hospital and patient [5, 52] .
Conclusion
Acute cholecystitis is managed differently in the United States and England. American patients are more likely to receive a definitive operation on their index admission. Patients in England who do not receive initial cholecystectomy are frequently readmitted with complications and have a lengthy wait for definitive management. The UK can provide greater value for the NHS, the patient and provider by improving access to, and ensuring the availability of, the required resources for prompt emergency care.
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